ACET adicetbio.com: Long-Term Debt to Capital Coefficient

Symbol and logo of brand Adicet Bio, Inc. (ACET)

Adicet Bio revenues rely on settlements with insurance funds and lymphoma treatment clinics. Drug production is organized through certified CDMO partners in California. The development strategy excludes mergers, focusing instead on seeking co-investors for clinical trials. Long-term debt-to-equity reflects credit risk dynamics, while 0.08 is recorded as the baseline value for the current financial burden.

ACET - adicetbio.com Long-Term Debt to Equity over the range 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for Adicet Bio Inc. (ACET)

- price and consensus price forecast:
Quote Chart Adicet|ACET - Analyst Consensus Forecast
- market capitalization data:
Market Value Adicet Bio, Inc.|ACET - Enterprise Value
- book capitalization data:
Book Value per Share Adicet Bio|ACET - Company Book Value|Market Value to Book Value adicetbio.com|ACET - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Adicet Bio|ACET - Long-Term Debt to Capital|Short-Term Debt to Capital Adicet|ACET - Company Total Debt|Debt to Net Assets Ratio Adicet Bio, Inc.
Initial company analysis:ACET, adicetbio.com
Core merchandise of Adicet Bio Inc.

The metric is calculated as the ratio of total liabilities with a maturity exceeding one year to total equity. It determines the extent of the company's dependence on external long-term financing relative to its net assets. For Adicet Bio (ACET), such borrowings are critical when upgrading bioreactors to meet ESG environmental standards. Analyzing the current long-term debt-to-equity trend allows for an assessment of the financing structure's stability.

Direct competitors

Long-Term Liabilities to Equity argenx N.V.|BioNTech Group (BNTX) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Abivax S.A. (ABVX)|Long-Term Debt to Capital ADMA (ADMA Biologics)|protagonist-inc.com - Long-Term Debt to Capital|Long-Term Debt to Equity Immunovant (IMVT)|KNSA: Long-Term Debt to Capital Coefficient|GRFS (Grifols Group) - Long-Term Debt to Equity|Adaptive Biotechnologies Inc. (ADPT) - Long-Term Debt to Equity Ratio|CLDX (Celldex Therapeutics) - Long-Term Debt to Capital|Long-Term Debt to Capital auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient Vera Therapeutics Inc (VERA)|Long-Term Debt to Capital DNTH|Pharvaris Pharma - Ratio of Long-Term Indebtedness to Capital|ABCL: Long-Term Debt to Equity|TRML: Long-Term Debt to Equity Ratio|PGEN (Precigen) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pharming Group NV|NKTR (Nektar) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital UPB|Long-Term Debt to Equity Zenas Biopharma Inc ZBIO|Long-Term Debt to Capital Ratio immunome.com (IMNM)|GOSS: Long-Term Debt to Capital|Long-Term Liabilities to Capital KalVista Pharma KALV|Septerna Corp - Long-Term Debt to Capital|PVLA - Long-Term Debt to Capital|Long-Term Debt to Capital Savara Inc.|rigel.com (RIGL) - Long-Term Debt to Capital Ratio|ANAB: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Astria Therapeutics Inc|Long-Term Debt to Capital ENGN (enGene Bio)|Long-Term Debt to Equity Ratio rapt.com (RAPT)|JBIO: Long-Term Debt to Capital|ACRS - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ratio Kyverna Therapeutics, Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Ratio Cabaletta Bio, Inc CABA|Ventyx Biosciences, Inc (VTYX) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital Theratechnologies Inc.|Long-Term Debt to Equity avalotx.com|ELDN (Eledon Pharmaceuticals, Inc.) - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital AGEN (Agenus, Inc.)|CLYM: Long-Term Debt to Equity|Long-Term Liabilities to Capital zurabio.com ZURA|aTyr Pharma, Inc. - Long-Term Debt to Capital|ADAG - Long-Term Debt to Capital|IMA (ikenaoncology.com) - Long-Term Debt to Capital|Shattuck Labs (STTK) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital EQ (Equillium Inc)|Long-Term Liabilities to Capital Connect Pharma (CNTB)|Long-Term Debt to Equity Ratio Immunic, Inc.|Long-Term Loans to Capital Ratio ATRA (atarabio.com)|InflaRx (IFRX) - Long-Term Debt to Equity|Long-Term Liabilities to Equity X4 Pharmaceuticals Inc. XFOR|Long-Term Debt to Capital Celularity Corp (CELU)|INMB - Long-Term Debt to Capital Coefficient|BRNS: Long-Term Debt to Capital|KZR (kezarlifesciences.com) - Long-Term Debt to Capital|SABS - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient AKTX|Long-Term Debt to Equity ENLV (Enlivex Therapeutics)|Long-Term Debt to Equity Ratio q32bio.com (QTTB)|Long-Term Debt to Capital GOVX (GeoVax Labs, Inc.)|EDSA - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio iBio (IBIO)|CARM - Long-Term Debt to Capital Coefficient|XTL Biopharmaceuticals, Ltd. - Long-Term Debt to Capital|BOLT (Bolt Biotherapeutics, Inc.) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity HCWB|Long-Term Debt to Equity Ratio APVO|Long-Term Debt to Equity AIM (AIM ImmunoTech)|Long-Term Debt to Equity Ratio aditxt.com ADTX|Long-Term Debt to Equity Ratio GRI (GRI Bio Corp)|XORTX Corp - Long-Term Debt to Capital|Vyome Holdings Inc (HIND) - Long-Term Debt to Equity|REVB - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital INDP|Scinai Immunotherapeutics Ltd (SCNI) - Long-Term Liabilities to Capital|CALI (CalciMedica Inc) - Long-Term Debt to Capital|Long-Term Debt to Capital Affimed Therapeutics|Long-Term Debt to Capital Allakos Inc. ALLK|Long-Term Debt to Capital Ratio hookipapharma.com (HOOK)|Long-Term Debt to Capital IGMS|Ratio of Long-Term Indebtedness to Capital iTeos Therapeutics Inc ITOS|OCEA: Long-Term Debt to Capital|TCBP - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital THRD